Evista Générique est utilisé pour traiter et prévenir l'ostéoporose (amincissement des os) chez les femmes qui sont postménopausées. Il est également utilisé pour réduire le risque de cancer du sein invasif chez certaines femmes qui sont postménopausées.
Moderate Weight Loss May Be Way to Lower Breast Cancer Risk For Overweight ... - Cancer Network
Telegraph.
US to Seek New Uses for Abandoned Drugs - Wall Street Journal
US to Seek New Uses for Abandoned DrugsWall Street JournalAs examples of drugs that earlier found new purposes, Dr.
NeuVax Founder Dr. Peoples Eliminates Speculation For Facts - Seeking Alpha
NeuVax Founder Dr.
Moderate weight loss cuts breast cancer risk - Times of India
Moderate weight loss cuts breast cancer riskTimes of IndiaThe results of the research could also be relevant to overweight women, who take breast cancer prevention drugs such as tamoxifen, raloxifene and exemestane, which either block the action of estrogen or stop its production.
Increased Mammograms Up to 65% Responsible for Breast Cancer Mortality Reduction - MarketWatch (press release)
Increased Mammograms Up to 65% Responsible for Breast Cancer Mortality ReductionMarketWatch (press release).